- Home
- HIMS
as 06-17-2025 4:00pm EST
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 6.0B | IPO Year: | N/A |
| Target Price: | $38.00 | AVG Volume (30 days): | 38.4M |
| Analyst Decision: | Hold | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.68 | EPS Growth: | N/A |
| 52 Week Low/High: | $13.47 - $72.98 | Next Earning Date: | 08-04-2025 |
| Revenue: | $1,784,353,000 | Revenue Growth: | 85.99% |
| Revenue Growth (this year): | 62.48% | Revenue Growth (next year): | 20.34% |
Stock Insider Trading Activity of Hims & Hers Health Inc. (HIMS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Chi Michael | HIMS | Chief Commercial Officer | Jun 10 '25 | Sell | $57.00 | 5,600 | $319,200.00 | 256,380 | |
| Chi Michael | HIMS | Chief Commercial Officer | Jun 5 '25 | Sell | $56.00 | 5,100 | $285,600.00 | 256,380 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | May 28 '25 | Sell | $52.98 | 11,581 | $613,537.06 | 39,153 | |
| Boughton Soleil | HIMS | Chief Legal Officer | May 27 '25 | Sell | $55.87 | 3,233 | $180,627.71 | 153,194 | |
| Becklund Irene | HIMS | PAO | May 22 '25 | Sell | $53.51 | 5,071 | $271,349.21 | 0 | |
| Dudum Andrew | HIMS | Chief Executive Officer | May 16 '25 | Sell | $58.61 | 175,661 | $10,251,387.69 | 148,380 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | May 15 '25 | Sell | $60.22 | 11,581 | $697,462.25 | 39,153 | |
| Boughton Soleil | HIMS | Chief Legal Officer | May 12 '25 | Sell | $56.00 | 3,235 | $181,160.00 | 153,194 | |
| Baird Melissa | HIMS | Chief Operating Officer | May 12 '25 | Sell | $56.38 | 33,333 | $1,867,376.22 | 805,083 | |
| Dudum Andrew | HIMS | Chief Executive Officer | Apr 28 '25 | Sell | $33.29 | 91,667 | $3,077,070.06 | 148,380 |
Latest Hims & Hers Health Inc. News
HIMS Breaking Stock News: Dive into HIMS Ticker-Specific Updates for Smart Investing
Motley Fool
a day ago
These 2 Growth Stocks Are No-Brainer Buys Right Now
Simply Wall St.
4 days ago
3 Growth Companies With High Insider Ownership And Up To 27% Earnings Growth
Simply Wall St.
5 days ago
June 2025's Select Stocks That Could Be Trading Below Estimated Value
Yahoo Finance
6 days ago
Eli Lilly telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to
Argus Research
7 days ago
HIMS: Raising target price to $58.00
Yahoo Finance Video
7 days ago
Eli Lilly telehealth deals to prevent sale of compounded GLP-1s
Yahoo Finance Video
14 days ago
Hims & Hers and Zava, Credo earnings, Kenvue: Trending Tickers
Yahoo Finance Video
14 days ago
Hims & Hers, Joby Aviation, Pinterest: Trending Tickers
Compare HIMS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HIMS Hims & Hers Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.